Short pediatric Crohn's disease activity index for quality improvement and observational research
- PMID: 20812330
- PMCID: PMC2998542
- DOI: 10.1002/ibd.21452
Short pediatric Crohn's disease activity index for quality improvement and observational research
Abstract
Background: Practical and objective instruments to assess pediatric Crohn's disease (CD) activity are required for observational research and quality improvement. The objectives were: 1) to determine the feasibility of completing the Pediatric Crohn's Disease Activity Index (PCDAI) and the Abbreviated PCDAI (APCDAI); and 2) to create a Short PCDAI by retaining and reweighting the most practical and informative components.
Methods: Physicians in the ImproveCareNow Collaborative for pediatric inflammatory bowel disease (IBD) were asked to record components of the PCDAI and assign a Physician Global Assessment (PGA) of disease severity at each patient encounter. We assessed the feasibility of the PCDAI, the APCDAI, and the individual index components by determining the proportion of visits in which data were recorded. We created a short index by retaining and reweighting components of the PCDAI completed in ≥80% of visits. The feasibility of the Short PCDAI and its ability to discriminate between PGA categories were evaluated using descriptive statistics.
Results: This study population included 1355 subjects with CD (6373 visits). The PCDAI and APCDAI were complete in 16.7% and 44.1% of visits, respectively. A Short PCDAI, including general well-being, abdominal pain, stools, weight, abdominal exam, and extraintestinal manifestations were completed in 66.5% of visits. The correlation between the Short PCDAI and PGA was similar to that of the PCDAI (r = 0.60, P < 0.001 versus 0.61, P < 0.001).
Conclusions: The Short PCDAI is a practical and valid tool to measure pediatric CD activity. Its use should facilitate quality improvement and observational research.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.
Conflict of interest statement
Figures
Similar articles
-
Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions.Inflamm Bowel Dis. 2012 Jan;18(1):55-62. doi: 10.1002/ibd.21649. Epub 2011 Feb 23. Inflamm Bowel Dis. 2012. PMID: 21351206
-
Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original?J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):68-72. doi: 10.1097/00005176-200407000-00014. J Pediatr Gastroenterol Nutr. 2004. PMID: 15187784
-
Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):254-260. doi: 10.1097/MPG.0000000000001227. J Pediatr Gastroenterol Nutr. 2017. PMID: 27050050
-
Well-defined and reliable clinical outcome assessments for pediatric Crohn disease: a critical need for drug development.J Pediatr Gastroenterol Nutr. 2015 Jun;60(6):729-36. doi: 10.1097/MPG.0000000000000793. J Pediatr Gastroenterol Nutr. 2015. PMID: 25793905 Review.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
Cited by
-
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.Nat Commun. 2024 Jun 3;15(1):4567. doi: 10.1038/s41467-024-48763-7. Nat Commun. 2024. PMID: 38830848 Free PMC article.
-
Natural History of Pediatric Patients With Crohn's Disease Treated With Mesalamine Therapy.JPGN Rep. 2023 Nov 3;4(4):e379. doi: 10.1097/PG9.0000000000000379. eCollection 2023 Nov. JPGN Rep. 2023. PMID: 38034435 Free PMC article.
-
Identifying predictors of clinical outcomes using the projection-predictive feature selection-a proof of concept on the example of Crohn's disease.Front Pediatr. 2023 Jul 28;11:1170563. doi: 10.3389/fped.2023.1170563. eCollection 2023. Front Pediatr. 2023. PMID: 37576142 Free PMC article.
-
Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease.J Comp Eff Res. 2023 Apr;12(4):e220136. doi: 10.57264/cer-2022-0136. Epub 2023 Feb 17. J Comp Eff Res. 2023. PMID: 36799351 Free PMC article.
-
Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn's Disease Receiving Biologics: A Retrospective Cohort Study.Crohns Colitis 360. 2022 Mar 18;4(2):otac009. doi: 10.1093/crocol/otac009. eCollection 2022 Apr. Crohns Colitis 360. 2022. PMID: 36777044 Free PMC article.
References
-
- Loftus EV, Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16(1):51–60. - PubMed
-
- Kappelman MD, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):1424–9. - PubMed
-
- Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol. 2003;98(5):1064–72. - PubMed
-
- Akobeng AK, et al. Quality of life in children with Crohn’s disease: a pilot study. J Pediatr Gastroenterol Nutr. 1999;28(4):S37–9. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical